Evogene Ltd
Company Profile
Business description
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment, followed by Industry.
Contact
13 Gad Feinstein Street
Park Rehovot
Ness Ziona
Rehovot7638517
ISRT: +972 89311900
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
75
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,774.80 | 86.80 | 1.00% |
CAC 40 | 7,633.56 | 95.99 | 1.27% |
DAX 40 | 23,657.69 | 388.68 | 1.67% |
Dow JONES (US) | 42,581.78 | 374.96 | 0.89% |
FTSE 100 | 8,798.33 | 40.29 | 0.46% |
HKSE | 24,184.91 | 495.78 | 2.09% |
NASDAQ | 19,630.97 | 183.56 | 0.94% |
Nikkei 225 | 38,790.56 | 436.47 | 1.14% |
NZX 50 Index | 12,467.48 | 65.17 | -0.52% |
S&P 500 | 6,025.17 | 57.33 | 0.96% |
S&P/ASX 200 | 8,555.50 | 80.60 | 0.95% |
SSE Composite Index | 3,420.57 | 38.98 | 1.15% |